BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2677808)

  • 1. Renal effects of indomethacin in patients with systemic lupus erythematosus.
    ter Borg EJ; de Jong PE; Meijer S; Kallenberg CG
    Nephron; 1989; 53(3):238-43. PubMed ID: 2677808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normotensive hyperreninemia in systemic lupus erythematosus. An indicator of tubular dysfunction.
    Herrera-Acosta J; Guerrero J; Erbessd ML; Paz-Barahona M; Chessal F; Alarcón-Segovia D; Peña JC
    Nephron; 1978; 22(1-3):128-37. PubMed ID: 745633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filtration fraction: an index of renal disease activity in patients with systemic lupus erythematosus.
    Favre H; Miescher PA
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():717-21. PubMed ID: 3991566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinicopathological study of renal hemodynamics in patients with systemic lupus erythematosus].
    Nakano M; Ueno M; Hasegawa H; Watanabe T; Kuroda T; Saeki T; Ito S; Arakawa M
    Nihon Jinzo Gakkai Shi; 1994 Sep; 36(9):1028-35. PubMed ID: 7967174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney.
    Mitnick PD; Greenberg A; DeOreo PB; Weiner BM; Coffman TM; Walker BR; Agus ZS; Goldfarb S
    Clin Pharmacol Ther; 1980 Nov; 28(5):680-9. PubMed ID: 7002426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function.
    Kallenberg CG; Schweitzer C; de Jong PE; Donker AJ; van der Hem GK
    Clin Nephrol; 1984 Nov; 22(5):223-9. PubMed ID: 6518673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive renal effects of indomethacin and dipyridamole in man.
    Seideman P; Sollevi A; Fredholm BB
    Br J Clin Pharmacol; 1987 Mar; 23(3):323-30. PubMed ID: 3567047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis.
    Wong F; Massie D; Hsu P; Dudley F
    Gastroenterology; 1993 Mar; 104(3):869-76. PubMed ID: 8440438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis.
    Kutyrina IM; Androsova SO; Warshavskii VA; Tareyeva IE
    Nephron; 1982; 32(3):244-8. PubMed ID: 6759952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hyperkalemia in systemic lupus erythematosus.
    Lee FO; Quismorio FP; Troum OM; Anderson PW; Do YS; Hsueh WA
    Arch Intern Med; 1988 Feb; 148(2):397-401. PubMed ID: 3277563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of prostaglandin synthesis suppresses the renal functional reserve in patients with lupus nephropathy].
    Herrera-Acosta J; Reyes PA; López Manay G; Padilla L; Cerdas Calderón M; Ruiz A; Pérez Grovas H
    Rev Invest Clin; 1987; 39(2):107-14. PubMed ID: 3310165
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Horizon AA; Wallace DJ
    Expert Opin Drug Saf; 2004 Jul; 3(4):273-8. PubMed ID: 15268645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular filtration rate and urinary albumin excretion rate in systemic lupus erythematosus.
    Cottiero RA; Madaio MP; Levey AS
    Nephron; 1995; 69(2):140-6. PubMed ID: 7723895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal prostaglandins on survival in patients with liver cirrhosis.
    Kawasaki H; Nosaka Y; Yamada S; Uemasu J; Hirayama C; Suyama A
    Am J Gastroenterol; 1989 Mar; 84(3):285-9. PubMed ID: 2919584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Gottlieb SS; Robinson S; Krichten CM; Fisher ML
    Am J Cardiol; 1992 Oct; 70(9):890-3. PubMed ID: 1529943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin and renal impairment in neonates.
    Akima S; Kent A; Reynolds GJ; Gallagher M; Falk MC
    Pediatr Nephrol; 2004 May; 19(5):490-3. PubMed ID: 15007713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Østensen M; Villiger PM
    Lupus; 2001; 10(3):135-9. PubMed ID: 11315341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus.
    Dent EL; Taylor EB; Turbeville HR; Ryan MJ
    Physiol Rep; 2020 Jul; 8(13):e14501. PubMed ID: 32652896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.